{"id":"intravitreal-triamcinolone","safety":{"commonSideEffects":[{"rate":"20-40","effect":"Elevated intraocular pressure"},{"rate":"10-30","effect":"Cataract progression"},{"rate":"0.1-1","effect":"Endophthalmitis"},{"rate":"1-5","effect":"Vitreous hemorrhage"},{"rate":"5-15","effect":"Floaters"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Triamcinolone acetonide is a synthetic glucocorticoid that binds to glucocorticoid receptors in ocular tissues, inhibiting inflammatory cytokine production and reducing edema. When administered intravitreally, it achieves high local concentrations in the posterior segment of the eye, making it effective for treating inflammatory and vascular retinal conditions without systemic exposure.","oneSentence":"Intravitreal triamcinolone is a corticosteroid injected directly into the eye that suppresses inflammation and reduces vascular permeability in retinal diseases.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:52.477Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diabetic macular edema"},{"name":"Retinal vein occlusion-related macular edema"},{"name":"Uveitic macular edema"},{"name":"Age-related macular degeneration (adjunctive)"}]},"trialDetails":[{"nctId":"NCT07129798","phase":"NA","title":"Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-01-18","conditions":"Macular Hole, Myopia","enrollment":20},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT06882551","phase":"PHASE4","title":"Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients","status":"COMPLETED","sponsor":"Khyber Teaching Hospital","startDate":"2023-04-01","conditions":"Diabetic Macular Edema (DME)","enrollment":82},{"nctId":"NCT06559488","phase":"NA","title":"IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2018-04-02","conditions":"Diabetic Retinopathy, Vitreous Hemorrhage","enrollment":18},{"nctId":"NCT00930189","phase":"PHASE2, PHASE3","title":"Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization","status":"WITHDRAWN","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2006-04","conditions":"Subfoveal Choroidal Neovascularization","enrollment":""},{"nctId":"NCT00600301","phase":"PHASE3","title":"Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study","status":"WITHDRAWN","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2008-01","conditions":"Diffuse Diabetic Macular Edema","enrollment":""},{"nctId":"NCT04075136","phase":"PHASE4","title":"Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-03-30","conditions":"Exudative Age Related Macular Degeneration","enrollment":""},{"nctId":"NCT00229931","phase":"NA","title":"Triamcinolone vs. Laser for Diabetic Macular Edema","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2005-11","conditions":"DIABETIC MACULAR EDEMA","enrollment":11},{"nctId":"NCT00915837","phase":"PHASE1","title":"Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema","status":"COMPLETED","sponsor":"SurModics, Inc.","startDate":"2005-06","conditions":"Diabetic Macular Edema","enrollment":31},{"nctId":"NCT05413330","phase":"PHASE2, PHASE3","title":"Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-09-12","conditions":"Diabete Type 2, Cataract, Triamcinolone Acetonide","enrollment":73},{"nctId":"NCT00309192","phase":"PHASE3","title":"Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema","status":"COMPLETED","sponsor":"Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA","startDate":"2006-04","conditions":"Diabetes Mellitus, Macular Edema","enrollment":292},{"nctId":"NCT04812977","phase":"NA","title":"Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Hayatabad Medical Complex","startDate":"2018-06-10","conditions":"Central Retinal Vein Occlusion With Macular Edema","enrollment":30},{"nctId":"NCT02556424","phase":"PHASE3","title":"Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2016-01","conditions":"Inflammatory Macular Edema","enrollment":114},{"nctId":"NCT04292756","phase":"NA","title":"Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment","status":"COMPLETED","sponsor":"The Filatov Institute of Eye Diseases and Tissue Therapy","startDate":"2018-03-27","conditions":"Age-Related Macular Degeneration","enrollment":63},{"nctId":"NCT05428683","phase":"NA","title":"Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery","status":"COMPLETED","sponsor":"Emad Abdel Aal Saliem","startDate":"2020-12-03","conditions":"Pharmacological Action","enrollment":84},{"nctId":"NCT02985619","phase":"PHASE2, PHASE3","title":"Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2016-07-21","conditions":"Diabetic Macular Edema","enrollment":100},{"nctId":"NCT02873026","phase":"PHASE3","title":"Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study","status":"COMPLETED","sponsor":"Moorfields Eye Hospital NHS Foundation Trust","startDate":"2014-10","conditions":"Eye Injury Trauma","enrollment":300},{"nctId":"NCT03238157","phase":"PHASE2, PHASE3","title":"Steroids for Early Treatment of Radiation Retinopathy","status":"WITHDRAWN","sponsor":"The Cleveland Clinic","startDate":"2022-02-01","conditions":"Radiation Retinopathy","enrollment":""},{"nctId":"NCT02949024","phase":"PHASE1, PHASE2","title":"Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2016-11-10","conditions":"Diabetic Macular Edema","enrollment":20},{"nctId":"NCT03126786","phase":"PHASE2","title":"Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2017-07-11","conditions":"Diabetic Macular Edema","enrollment":71},{"nctId":"NCT03203447","phase":"PHASE3","title":"Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO","status":"TERMINATED","sponsor":"Clearside Biomedical, Inc.","startDate":"2018-03-05","conditions":"Macular Edema, Retinal Vein Occlusion","enrollment":325},{"nctId":"NCT02980874","phase":"PHASE3","title":"Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO","status":"TERMINATED","sponsor":"Clearside Biomedical, Inc.","startDate":"2017-01-31","conditions":"Macular Edema, Retinal Vein Occlusion","enrollment":460},{"nctId":"NCT01789320","phase":"PHASE1, PHASE2","title":"Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2013-02","conditions":"Uveitis, Intermediate Uveitis, Posterior Uveitis","enrollment":11},{"nctId":"NCT02303184","phase":"PHASE2","title":"Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2015-01","conditions":"Macular Edema, Retinal Vein Occlusion","enrollment":46},{"nctId":"NCT02255032","phase":"PHASE2","title":"Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","startDate":"2014-10","conditions":"Uveitis, Macular Edema, Uveitis, Posterior","enrollment":22},{"nctId":"NCT04460001","phase":"PHASE2, PHASE3","title":"Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-05-16","conditions":"Ophthalmopathy","enrollment":100},{"nctId":"NCT04153253","phase":"PHASE4","title":"Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage","status":"COMPLETED","sponsor":"Al Hadi Hospital","startDate":"2018-03-07","conditions":"Diabetic Vitreous Hemorrhage","enrollment":34},{"nctId":"NCT00444600","phase":"PHASE3","title":"Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2007-03","conditions":"Diabetic Retinopathy, Diabetic Macular Edema","enrollment":691},{"nctId":"NCT02441907","phase":"PHASE4","title":"Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2015-08","conditions":"Diabetic Macular Edema","enrollment":16},{"nctId":"NCT02221453","phase":"PHASE2","title":"Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2015-09","conditions":"Diabetic Macular Edema","enrollment":3},{"nctId":"NCT04069780","phase":"NA","title":"Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Azza Mohamed Ahmed Said","startDate":"2019-03-13","conditions":"Safety, Efficacy","enrollment":45},{"nctId":"NCT00563940","phase":"","title":"Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2007-03","conditions":"Diabetic Macular Edema","enrollment":30},{"nctId":"NCT02598869","phase":"PHASE4","title":"Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema","status":"WITHDRAWN","sponsor":"Oregon Health and Science University","startDate":"2015-11-30","conditions":"Uveitis, Cystoid Macular Edema","enrollment":""},{"nctId":"NCT02374060","phase":"PHASE3","title":"PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2015-06-16","conditions":"Macular Edema, Uveitis","enrollment":192},{"nctId":"NCT02806752","phase":"PHASE4","title":"Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy","status":"UNKNOWN","sponsor":"Aier School of Ophthalmology, Central South University","startDate":"2017-01","conditions":"Wet Macular Degeneration","enrollment":120},{"nctId":"NCT02447185","phase":"PHASE3","title":"25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial","status":"UNKNOWN","sponsor":"JUNYAN ZHANG","startDate":"2015-06","conditions":"Proliferative Diabetic Retinopathy","enrollment":200},{"nctId":"NCT01532765","phase":"NA","title":"Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal","status":"TERMINATED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2011-09","conditions":"Epiretinal Membrane","enrollment":13},{"nctId":"NCT02294656","phase":"PHASE1","title":"Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide","status":"COMPLETED","sponsor":"Soll Eye","startDate":"2014-11","conditions":"CYSTOID MACULAR EDEMA","enrollment":4},{"nctId":"NCT00105027","phase":"PHASE3","title":"The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study","status":"COMPLETED","sponsor":"The Emmes Company, LLC","startDate":"2004-10","conditions":"Macular Edema, Cystoid, Retinal Vein Occlusion","enrollment":682},{"nctId":"NCT01243086","phase":"PHASE2","title":"OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab","status":"COMPLETED","sponsor":"McMaster University","startDate":"2011-03","conditions":"Wet Macular Degeneration","enrollment":10},{"nctId":"NCT00780780","phase":"PHASE3","title":"Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2007-07","conditions":"Diabetic Macular Edema","enrollment":40},{"nctId":"NCT01267422","phase":"NA","title":"Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)","status":"COMPLETED","sponsor":"Bin Li","startDate":"2011-04","conditions":"Leber Hereditary Optic Neuropathy","enrollment":9},{"nctId":"NCT02457026","phase":"NA","title":"Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2016-01","conditions":"Neovascular Age-related Macular Degeneration","enrollment":""},{"nctId":"NCT00100009","phase":"PHASE3","title":"Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2004-12-09","conditions":"Macular Degeneration","enrollment":30},{"nctId":"NCT00071227","phase":"PHASE1","title":"Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2003-10-15","conditions":"Macular Degeneration, Retinal Vein Occlusion","enrollment":16},{"nctId":"NCT00105404","phase":"PHASE3","title":"Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2005-03-09","conditions":"Diabetic Retinopathy, Diabetic Macular Edema, DME","enrollment":5},{"nctId":"NCT00101764","phase":"PHASE1","title":"Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2005-01-05","conditions":"Macular Degeneration, Retinal Vein Occlusion, Diabetic Retinopathy","enrollment":120},{"nctId":"NCT01774474","phase":"PHASE3","title":"PRevention of Macular EDema After Cataract Surgery","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2013-07-10","conditions":"Cystoid Macular Edema, Cataract, Diabetes Mellitus","enrollment":1127},{"nctId":"NCT02379000","phase":"PHASE4","title":"TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2015-01","conditions":"Exudative Retinal Detachment, Uveal Melanoma","enrollment":50},{"nctId":"NCT00561236","phase":"","title":"Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2007-04","conditions":"Secondary Adrenal Insufficiency","enrollment":28},{"nctId":"NCT00367133","phase":"PHASE3","title":"Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2004-07","conditions":"Diabetic Macular Edema","enrollment":840},{"nctId":"NCT00445003","phase":"PHASE3","title":"Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2007-03","conditions":"Proliferative Diabetic Retinopathy, Diabetic Macular Edema","enrollment":333},{"nctId":"NCT02328118","phase":"PHASE2, PHASE3","title":"25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China","status":"UNKNOWN","sponsor":"JUNYAN ZHANG","startDate":"2015-02","conditions":"Proliferative Diabetic Retinopathy","enrollment":120},{"nctId":"NCT00737971","phase":"PHASE4","title":"Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Rubens Belfort Jr.","startDate":"2008-08","conditions":"Diabetic Macular Edema","enrollment":142},{"nctId":"NCT00682539","phase":"PHASE4","title":"Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2007-10","conditions":"Diabetic Macular Edema","enrollment":71},{"nctId":"NCT00242580","phase":"PHASE3","title":"A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-09","conditions":"Macular Degeneration, Choroidal Neovascularization","enrollment":111},{"nctId":"NCT01504074","phase":"","title":"Morphological and Functional Evaluation of Irvine-Gass Syndrome","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-11","conditions":"Irvine Gass Syndrome","enrollment":50},{"nctId":"NCT01746875","phase":"NA","title":"A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes","status":"TERMINATED","sponsor":"Norwegian University of Science and Technology","startDate":"2014-02","conditions":"Macular Degeneration, Retinal Detachment","enrollment":9},{"nctId":"NCT00685100","phase":"PHASE3","title":"Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2004-01","conditions":"Neovascular Age Related Macular Degeneration","enrollment":40},{"nctId":"NCT00764244","phase":"PHASE3","title":"Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2005-01","conditions":"Diabetic Macular Edema, Diabetes","enrollment":72},{"nctId":"NCT00815360","phase":"PHASE2","title":"Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion","status":"COMPLETED","sponsor":"Retina Associates of Florida, P.A.","startDate":"2008-02","conditions":"Diabetic Macular Edema","enrollment":22},{"nctId":"NCT00846625","phase":"PHASE2","title":"Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2009-11","conditions":"Macular Edema, Uveitis","enrollment":""},{"nctId":"NCT02310295","phase":"NA","title":"Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-01","conditions":"Diabetic Macular Edema","enrollment":45},{"nctId":"NCT01175395","phase":"PHASE1, PHASE2","title":"20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2010-09","conditions":"Age-Related Macular Degeneration, Choroidal Neovascularization","enrollment":10},{"nctId":"NCT00523406","phase":"PHASE3","title":"Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2005-08","conditions":"Macular Degeneration","enrollment":40},{"nctId":"NCT00997191","phase":"PHASE3","title":"Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-10","conditions":"Diabetic Macular Edema","enrollment":12},{"nctId":"NCT01614509","phase":"NA","title":"Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Yeungnam University College of Medicine","startDate":"2012-01","conditions":"Branch Retinal Vein Occlusion","enrollment":45},{"nctId":"NCT00315640","phase":"PHASE2","title":"Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2005-12","conditions":"Eye Diseases","enrollment":70},{"nctId":"NCT00211419","phase":"PHASE1","title":"Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Manhattan Eye, Ear & Throat Hospital","startDate":"","conditions":"Maculopathy, Age-Related","enrollment":""},{"nctId":"NCT00805064","phase":"PHASE3","title":"Combined Triple Procedure in Retinal Vein Occlusion (RVO)","status":"COMPLETED","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"2006-01","conditions":"Retinal Vein Occlusion","enrollment":40},{"nctId":"NCT00806169","phase":"PHASE3","title":"Combined Triple Therapy in Diabetic Retinopathy (DRP)","status":"COMPLETED","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"2006-04","conditions":"Macular Edema, Diabetic Retinopathy","enrollment":40},{"nctId":"NCT01299129","phase":"","title":"Functional and Morphologic Aspects of Intravitreal Triamcinolone for Uveitis-associated Cystoid Macular Edema","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2009-06","conditions":"Uveitis Related Cystoid Macular Edema","enrollment":30},{"nctId":"NCT00376701","phase":"PHASE2","title":"Combination Therapy for Age-Related Macular Degeneration.","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2006-09","conditions":"Age Related Macular Degeneration","enrollment":103},{"nctId":"NCT01404364","phase":"NA","title":"Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye","status":"COMPLETED","sponsor":"Hospital Governador Celso Ramos","startDate":"2010-01","conditions":"Blind Painful Eye, Refractory Glaucoma, Control of Pain Through Drug Injection","enrollment":36},{"nctId":"NCT01342159","phase":"NA","title":"Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema","status":"COMPLETED","sponsor":"Hallym University Medical Center","startDate":"2009-03","conditions":"Diabetic Macular Edema","enrollment":80},{"nctId":"NCT01330524","phase":"PHASE1, PHASE2","title":"Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2010-01","conditions":"Acute Nonarteritic Anterior Ischemic Optic Neuropathy","enrollment":16},{"nctId":"NCT01249937","phase":"PHASE2","title":"Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2011-01","conditions":"Wet Macular Degeneration","enrollment":30},{"nctId":"NCT01202461","phase":"PHASE1","title":"Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME)","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-08","conditions":"Diabetic Retinopathy, Macular Edema","enrollment":41},{"nctId":"NCT01178697","phase":"PHASE2","title":"Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2010-01","conditions":"Central Retinal Vein Occlusion","enrollment":""},{"nctId":"NCT00148330","phase":"PHASE2, PHASE3","title":"Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study","status":"COMPLETED","sponsor":"University of Sydney","startDate":"2005-05","conditions":"Diabetic Macular Oedema","enrollment":64},{"nctId":"NCT00148265","phase":"PHASE2, PHASE3","title":"A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema","status":"COMPLETED","sponsor":"University of Sydney","startDate":"2005-04","conditions":"Diabetic Macular Oedema","enrollment":54},{"nctId":"NCT00447031","phase":"NA","title":"Combination Therapy for Neovascular Age Related Macular Degeneration","status":"WITHDRAWN","sponsor":"Yonsei University","startDate":"2007-03","conditions":"Macular Degeneration","enrollment":""},{"nctId":"NCT01053858","phase":"NA","title":"Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision","status":"COMPLETED","sponsor":"Hallym University Medical Center","startDate":"2008-01","conditions":"Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity","enrollment":38},{"nctId":"NCT01044329","phase":"PHASE2","title":"Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2010-01","conditions":"Branch Retinal Vein Occlusion","enrollment":90},{"nctId":"NCT00532142","phase":"PHASE2, PHASE3","title":"The ROVO Study: Radial Optic Neurotomy for CVO","status":"COMPLETED","sponsor":"Rudolf Foundation Clinic","startDate":"2005-04","conditions":"Central Retinal Vein Occlusion","enrollment":""},{"nctId":"NCT00801450","phase":"PHASE1, PHASE2","title":"Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2007-09","conditions":"Diabetic Macular Edema","enrollment":24},{"nctId":"NCT00744666","phase":"PHASE4","title":"IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids","status":"UNKNOWN","sponsor":"Hotel Dieu Hospital","startDate":"2008-09","conditions":"Vitreoretinal Disease, Ocular Hypertension","enrollment":70},{"nctId":"NCT00893854","phase":"PHASE1","title":"The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"","conditions":"Uveitis, Cystoid Macular Edema","enrollment":""},{"nctId":"NCT00874744","phase":"PHASE2","title":"Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Universidade Federal de Goias","startDate":"2008-03","conditions":"Diabetic Macular Edema","enrollment":13},{"nctId":"NCT00849537","phase":"PHASE1, PHASE2","title":"The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2008-04","conditions":"Diabetic Retinopathy","enrollment":""},{"nctId":"NCT00371111","phase":"PHASE1","title":"To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2006-08","conditions":"Resistant Cystoid Macular Edema","enrollment":40},{"nctId":"NCT00370370","phase":"PHASE3","title":"Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2005-11","conditions":"Neovascular Age-Related Macular Degeneration","enrollment":""},{"nctId":"NCT00370266","phase":"PHASE2","title":"Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2003-02","conditions":"Branch Retinal Vein Occlusion","enrollment":30},{"nctId":"NCT00407849","phase":"PHASE1, PHASE2","title":"Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2006-10","conditions":"Diabetic Retinopathy","enrollment":50},{"nctId":"NCT00668239","phase":"NA","title":"Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2004-09","conditions":"Macular Edema","enrollment":14},{"nctId":"NCT00612261","phase":"NA","title":"Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2006-10","conditions":"Macular Edema, Branch Retinal Vein Occlusion","enrollment":40},{"nctId":"NCT00140803","phase":"PHASE2","title":"Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"Manhattan Eye, Ear & Throat Hospital","startDate":"2003-10","conditions":"Age-Related Macular Degeneration","enrollment":106},{"nctId":"NCT00491712","phase":"NA","title":"Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2005-09","conditions":"Neovascular Glaucoma","enrollment":49},{"nctId":"NCT00300014","phase":"NA","title":"Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2006-01","conditions":"Post Vitrectomy State, Recurrent Diabetic Vitreous Hemorrhage","enrollment":30},{"nctId":"NCT00476918","phase":"PHASE1","title":"Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Heidelberg University","startDate":"2006-07","conditions":"Diabetic Retinopathy, Diabetic Macular Edema","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1253,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Triancinolona (Ophthalmos)"],"phase":"phase_3","status":"active","brandName":"Intravitreal triamcinolone","genericName":"Intravitreal triamcinolone","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intravitreal triamcinolone is a corticosteroid injected directly into the eye that suppresses inflammation and reduces vascular permeability in retinal diseases. Used for Diabetic macular edema, Retinal vein occlusion-related macular edema, Uveitic macular edema.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}